Maintenance of efficacy and safety with lebrikizumab up to one year of treatment in patients with moderate-to-severe atopic dermatitis with or without topical corticosteroids

被引：0
|
作者：
Guttman-Yassky, E. [1 ]
Weidinger, S. [2 ]
Silverberg, J. [3 ]
Gooderham, M. [4 ]
Thyssen, J. [5 ]
Irvine, A. [6 ]
Elmaraghy, H. [7 ]
Natalie, C. [7 ]
Hu, C. [7 ]
Pierce, E. [7 ]
Gil, E. G. [8 ]
Simpson, E. [9 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[2] Univ Hosp SchleswigHolstein, Dept Dermatol & Allergy, Kiel, Germany
[3] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA
[4] Skin Ctr Dermatol, Peterborough, ON, Canada
[5] Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark
[6] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland
[7] Eli Lilly & Co, Indianapolis, IN USA
[8] Almirall SA, Barcelona, Spain
[9] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
94
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [31] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L. R.
    Hahn, N.
    Nickoloff, B. J.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R. J.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
  • [32] Efficacy and safety of dupilumab with concomitant topical corticosteroids for up to 1 year in moderate-to-severe atopic dermatitis: a randomized, placebo-controlled phase III trial (CHRONOS)
    Blauvelt, A.
    Gooderham, M.
    Foley, P.
    Griffiths, C. E. M.
    Cather, J. C.
    de Bruin-Weller, M.
    Soo, Y.
    Akinlade, B.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 10 - 10
  • [33] The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
    Bashrahil, Bader
    Alzahrani, Ziyad
    Samarkandy, Sahal
    Aman, Abdullah
    Jfri, Abdulhadi
    [J]. FRONTIERS IN MEDICINE, 2023, 9
  • [34] Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis A Randomized Clinical Trial
    Reich, Kristian
    Kabashima, Kenji
    Peris, Ketty
    Silverberg, Jonathan, I
    Eichenfield, Lawrence F.
    Bieber, Thomas
    Kaszuba, Aleksandra
    Kolodsick, Jill
    Yang, Fan E.
    Gamalo, Margaret
    Brinker, Dennis R.
    Delozier, Amy M.
    Janes, Jonathan M.
    Nunes, Fabio P.
    Thyssen, Jacob P.
    Simpson, Eric L.
    [J]. JAMA DERMATOLOGY, 2020, 156 (12) : 1333 - 1343
  • [35] Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis
    Moore, C
    Ehlayel, MS
    Junprasert, J
    Sorensen, RU
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (05) : 452 - 458
  • [36] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis: A systematic review
    Zhao, Dan-Jie
    Li, Xia
    Lin, Hai-Xia
    Zheng, Hong
    Zhou, Di
    Tang, Peng
    [J]. PLOS ONE, 2024, 19 (07):
  • [37] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    [J]. ALLERGY, 2024, 79 (01) : 174 - 183
  • [38] Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Thaci, Diamant
    Irvine, Alan D.
    Gold, Linda Stein
    Blauvelt, Andrew
    Simpson, Eric L.
    Chu, Chia-Yu
    Liu, Zhuqing
    Lima, Renata Gontijo
    Pillai, Sreekumar G.
    Seneschal, Julien
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (12): : 1080 - 1091
  • [39] Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from eight trials
    Gold, Linda Stein
    Thaci, Diamant
    Thyssen, Jacob P.
    Gooderham, Melinda
    Laquer, Vivian
    Natalie, Chitra R.
    Zhao, Fangyi
    Meskimen, Eric
    ElMaraghy, Hany
    Montmayeur, Sonia
    Jimenez, Gemma
    de Bruin-Weller, Marjolein
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [40] Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis
    Jonathan I. Silverberg
    H. Chih-ho Hong
    Brian M. Calimlim
    Wan-Ju Lee
    Henrique D. Teixeira
    Eric B. Collins
    Marjorie M. Crowell
    Scott J. Johnson
    April W. Armstrong
    [J]. Dermatology and Therapy, 2023, 13 : 2247 - 2264
12345